Trials / Completed
CompletedNCT02819050
Effective Approaches & Strategies to Ease Off Nasal CPAP In Preterm Infants
A Prospective Randomized Controlled Tiral Comparing Sprinting Versus Non-sprinting Approach to Wean Nasal Continous Positive Airway Pressure Support in Premature Infants Born at Less Than 30 Weeks Gestational Age
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center · Academic / Other
- Sex
- All
- Age
- 26 Weeks
- Healthy volunteers
- Not accepted
Summary
Though Nasal Continuous Positive Airway Pressure (NCPAP) is a commonly used form of non-invasive neonatal respiratory support, the optimal method of weaning off NCPAP is not well established. In this prospective, two-center randomized control trial we hypothesize that gradually increasing time off NCPAP (sprinting) increases the success of weaning NCPAP off in infants born between 23 0/7-30 6/7 weeks of gestational age.
Detailed description
Eligible infants admitted to two Neonatal Intensive Care Units (NICUs) were randomized to a sprinting (SP) vs. a non-sprinting (NSP) protocol, both over 4 days. Infants assigned to the SP group sprinted twice daily for 3h (day 1), 6h (day 2), 9h (day 3) \& then 24h back on NCPAP (day 4) before switching to nasal cannula (NC) on day 5. Infants in the NSP group were maintained on NCPAP of 5 cm of water for the first 4 days before switching to NC on day 5, similar to the SP group. Infants in both groups were observed for the next 3 days (day 5-7) to ensure stability off CPAP
Conditions
- Neonatal Respiratory Distress Syndrome
- Extremely Low Birth Weight Infant (ELBW)
- BronchoPulmonary Dysplasia
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | NCPAP | Nasal Continuous Positive Airway Pressure |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2016-01-01
- Completion
- 2016-01-01
- First posted
- 2016-06-30
- Last updated
- 2021-12-10
- Results posted
- 2021-12-10
Source: ClinicalTrials.gov record NCT02819050. Inclusion in this directory is not an endorsement.